ProShare Advisors’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-10,026
| Closed | -$80.1K | – | 2079 |
|
|
2025
Q2 | $80.1K | Sell |
10,026
-713
| -7% | -$5K | ﹤0.01% | 1912 |
|
|
2025
Q1 | $78K | Sell |
10,739
-3,231
| -23% | -$23.5K | ﹤0.01% | 1882 |
|
|
2024
Q4 | $96.3K | Buy |
+13,970
| New | +$96.1K | ﹤0.01% | 2081 |
|
|
2024
Q3 | – | Sell |
-505,594
| Closed | -$5.33M | – | 2101 |
|
|
2024
Q2 | $5.33M | Sell |
505,594
-92,020
| -15% | -$1.17M | 0.01% | 489 |
|
|
2024
Q1 | $8.27M | Buy |
597,614
+159,831
| +37% | +$2.5M | 0.02% | 371 |
|
|
2023
Q4 | $8.5M | Buy |
437,783
+97,541
| +29% | +$1.8M | 0.03% | 380 |
|
|
2023
Q3 | $7.22M | Buy |
340,242
+101,714
| +43% | +$2.64M | 0.02% | 419 |
|
|
2023
Q2 | $7.92M | Buy |
238,528
+8,278
| +4% | +$305K | 0.02% | 397 |
|
|
2023
Q1 | $9.05M | Buy |
230,250
+6,458
| +3% | +$268K | 0.03% | 360 |
|
|
2022
Q4 | $9.44M | Sell |
223,792
-586,518
| -72% | -$22.6M | 0.03% | 298 |
|
|
2022
Q3 | $27M | Buy |
810,310
+102,541
| +14% | +$4.27M | 0.1% | 173 |
|
|
2022
Q2 | $30.6M | Buy |
707,769
+36,884
| +5% | +$1.69M | 0.1% | 173 |
|
|
2022
Q1 | $32.1M | Sell |
670,885
-65,846
| -9% | -$3.26M | 0.07% | 203 |
|
|
2021
Q4 | $37.4M | Buy |
736,731
+173,643
| +31% | +$7.72M | 0.07% | 187 |
|
|
2021
Q3 | $22.8M | Buy |
563,088
+26,979
| +5% | +$1.37M | 0.06% | 210 |
|
|
2021
Q2 | $30.4M | Buy |
536,109
+255,119
| +91% | +$14.5M | 0.09% | 197 |
|
|
2021
Q1 | $14.9M | Sell |
280,990
-6,091
| -2% | -$332K | 0.05% | 285 |
|
|
2020
Q4 | $15.7M | Sell |
287,081
-35,349
| -11% | -$1.86M | 0.06% | 256 |
|
|
2020
Q3 | $16.2M | Sell |
322,430
-149,446
| -32% | -$7.09M | 0.07% | 201 |
|
|
2020
Q2 | $18M | Buy |
471,876
+77,406
| +20% | +$2.49M | 0.1% | 173 |
|
|
2020
Q1 | $8.62M | Buy |
394,470
+44,221
| +13% | +$1.33M | 0.06% | 277 |
|
|
2019
Q4 | $14.4M | Sell |
350,249
-9,700
| -3% | -$396K | 0.07% | 248 |
|
|
2019
Q3 | $15.3M | Buy |
359,949
+91,274
| +34% | +$3.83M | 0.09% | 192 |
|
|
2019
Q2 | $13.3M | Buy |
268,675
+97,502
| +57% | +$4.96M | 0.08% | 218 |
|
|
2019
Q1 | $8.19M | Buy |
171,173
+42,227
| +33% | +$2.56M | 0.05% | 342 |
|
|
2018
Q4 | $7.91M | Buy |
128,946
+15,205
| +13% | +$1.03M | 0.06% | 296 |
|
|
2018
Q3 | $9.38M | Buy |
113,741
+5,332
| +5% | +$424K | 0.06% | 232 |
|
|
2018
Q2 | $8.48M | Sell |
108,409
-4,879
| -4% | -$378K | 0.06% | 259 |
|
|
2018
Q1 | $8.35M | Buy |
113,288
+108,653
| +2,344% | +$7.71M | 0.05% | 279 |
|
|
2017
Q4 | $316K | Buy |
4,635
+1,231
| +36% | +$79.6K | ﹤0.01% | 1358 |
|
|
2017
Q3 | $209K | Sell |
3,404
-297
| -8% | -$18.2K | ﹤0.01% | 1275 |
|
|
2017
Q2 | $233K | Sell |
3,701
-707
| -16% | -$40.3K | ﹤0.01% | 1281 |
|
|
2017
Q1 | $245K | Buy |
+4,408
| New | +$227K | ﹤0.01% | 1348 |
|
Other funds holding NUS
PGCM
ProShare Advisors's NUS Position: Q3 2025 in Review
ProShare Advisors sold out of Nu Skin (NUS) in Q3 2025, closing a stake of 10,026 shares — an estimated $80.1K sold.
ProShare Advisors first reported a position in NUS in Q1 2017 and held it in 33 quarters. The position peaked at $37.4M in Q4 2021. 194 funds tracked by Wall St. Rank hold NUS as of Q3 2025.
- ProShare Advisors reported no remaining Nu Skin position as of Q3 2025 after selling out during the quarter.
- ProShare Advisors sold 10,026 Nu Skin shares in Q3 2025, an estimated $80.1K.
- ProShare Advisors first reported a position in Nu Skin in Q1 2017 and held it in 33 quarters.
- ProShare Advisors's Nu Skin position peaked at $37.4M in Q4 2021.
- 194 funds tracked by Wall St. Rank held Nu Skin as of Q3 2025.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.